Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT06295731 |
Title | INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS>=20 HNSCC (HexAgon-HN) |
Acronym | HexAgon-HN |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Inhibrx Biosciences, Inc |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Medical Center | RECRUITING | Duarte | California | 91010 | United States | Details |
Mid Florida Hematology and Oncology Center | RECRUITING | Orange City | Florida | 32763 | United States | Details |
Massachusetts General Hospital | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
Washington University St. Louis | RECRUITING | Saint Louis | Missouri | 63110 | United States | Details |
Oncology Hematology West, PC dba Nebraska Cancer Specialists | RECRUITING | Omaha | Nebraska | 68130 | United States | Details |
Christus St. Vincent Regional Cancer Center | RECRUITING | Santa Fe | New Mexico | 87505 | United States | Details |